Sorry, you need to enable JavaScript to visit this website.

Clinical Study of a New Pneumococcal Vaccine in Adults 60 through 64 Years of Age

A Phase 2, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age

Category & Conditions: Vaccine-related Conditions
Medicine: PF-06482077 Identifier (NCT): NCT03313037
Protocol ID: B7471002
Open Plain Language Summary Result: Click here